Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists (ASA) Class 1 or 2 or 3~* Scheduled to undergo an elective in-patient laparoscopic cholecystectomy procedure under general anesthesia with total intravenous anesthesia (TIVA) using propofol and remifentanil~* Eligible to undergo rocuronium-induced NMB for endotracheal intubation and maintenance of NMB~* Will recover in the post-anesthesia care unit (PACU) and remain in the hospital for at least 48 hours following the surgical procedure (or at least 24 hours following the surgical procedure, if local practice does not allow 48 hours of hospitalization post surgery)~* Body mass index (BMI) ≤35~* Willing and able to adhere to visit schedules including all required study assessments on Day 3 through 8 (daily pain and medication diary entry)~* For sexually active female participants of child-bearing potential - able to use a medically accepted method of contraception through 7 days after receiving protocol-specified medication~Exclusion criteria:~* Neuromuscular disorders that may affect NMB and/or trial assessments~* Lifetime history of previous abdominal surgery, including laparotomies, Cesarean section, laparoscopic procedures or diagnostic laparoscopies~* Substance abuse or dependence (excluding nicotine) within the past 6 months~* History of a chronic pain condition (requiring continuous/daily pain medication prior to surgery)~* For female participants - lifetime history of a Cesarean section, or has given birth to one or more children within the last year, or is currently pregnant or has the intention to become pregnant between randomization and pregnancy follow-up contact ≥30 days after administration of trial treatments (rocuronium, sugammadex)~* Evidence of acute cholecystitis~* Dialysis-dependency or suspected of having severe renal insufficiency~* Significant hepatic dysfunction that would prevent participation in the trial~* History of or family history of malignant hyperthermia~* Allergy to trial treatments (rocuronium or sugammadex) or their excipients, to opioids/opiates, or other medication used during general anesthesia~* Received or is planned to receive toremifene or fusidic acid within 24 hours before or after receiving rocuronium or sugammadex~* Expected transfer to an Intensive Care Unit after surgery~* Any clinically significant condition or situation, other than the reason for the cholecystectomy that would interfere with the trial evaluations or optimal participation in the trial~* Used any investigational drugs within 30 days of randomization~* Participated in any other clinical trial within 30 days of signing the informed consent form of the current trial~* Participated in any other clinical trial involving any personnel of the investigational or Sponsor staff directly involved with this trial~* Is a family member of any personnel of the investigational or Sponsor staff directly involved with this trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard NMB and Standard Insufflation Pressure (Type: EXPERIMENTAL): Treatment condition for this arm is Standard NMB (depth of blockade at a targeted Train of Four \[TOF\] ratio of 10%)/Standard insufflation pressure (starting pressure of 12 mmHg).
- Standard NMB and Low Insufflation Pressure (Type: EXPERIMENTAL): Treatment condition for this arm is Standard NMB (depth of blockade at a targeted TOF ratio of 10%)/Low insufflation pressure (starting pressure of 8 mmHg).
- Deep NMB and Standard Insufflation Pressure (Type: EXPERIMENTAL): Treatment condition for this arm is Deep NMB (depth of blockade of 1-2 PTCs)/Standard insufflation pressure (starting pressure of 12 mmHg).
- Deep NMB and Low Insufflation Pressure (Type: EXPERIMENTAL): Treatment condition for this arm is Deep NMB (depth of blockade of 1-2 PTCs)/Low insufflation pressure (starting pressure of 8 mmHg).

Based on this trial design, predict the completion outcome and termination type (if applicable).